Ambiguity abounds around the terms for pharmaceutical goods under the U.S.-EU trade truce agreed Sunday. Pharma firms are urging clarity over whether their products will be subject to 15% tariffs on ...
The amended deal between Microsoft (MSFT) and OpenAI (OPENAI) should provide less ambiguity around artificial general ...
It’s unclear if the next new months will mark a turning point for the struggling farm-machinery sector, with minimal details on the US-China trade deal keeping manufacturers wondering when growers ...
Pharma firms are calling for clarity on tariffs imposed under the new U.S.-EU trade agreement, as analysts warn that punitive sector-specific levies could risk blowing up the entire deal. Ambiguity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results